SFG
GPCR icon

SVB Financial Group’s Structure Therapeutics GPCR Stock Holding History

SVB Financial Group’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-35,353
Closed -$1.78M – 18
2023
Q3 		$1.78M Hold
35,353
– – 3.35% 5
2023
Q2 		$1.47M Hold
35,353
– – 2.78% 5
2023
Q1 		$841K Buy
+35,353
New +$831K 1.61% 7

Other funds holding GPCR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

SVB Financial Group's GPCR Position: Q4 2023 in Review

SVB Financial Group sold out of Structure Therapeutics (GPCR) in Q4 2023, closing a stake of 35,353 shares — an estimated $1.78M sold.

SVB Financial Group first reported a position in GPCR in Q1 2023 and held it in 3 quarters. The position peaked at $1.78M in Q3 2023. 121 funds tracked by Wall St. Rank hold GPCR as of Q4 2023.

  • SVB Financial Group reported no remaining Structure Therapeutics position as of Q4 2023 after selling out during the quarter.
  • SVB Financial Group sold 35,353 Structure Therapeutics shares in Q4 2023, an estimated $1.78M.
  • SVB Financial Group first reported a position in Structure Therapeutics in Q1 2023 and held it in 3 quarters.
  • SVB Financial Group's Structure Therapeutics position peaked at $1.78M in Q3 2023.
  • 121 funds tracked by Wall St. Rank held Structure Therapeutics as of Q4 2023.

Based on SVB Financial Group's 13F filing for Q4 2023, filed 14 Feb 2024.